Department of Chemical Engineering, Brigham Young University, Provo, Utah, USA.
Biotechnol Prog. 2023 May-Jun;39(3):e3332. doi: 10.1002/btpr.3332. Epub 2023 Mar 5.
Cell-free protein synthesis (CFPS) is a versatile biotechnology platform enabling a broad range of applications including clinical diagnostics, large-scale production of officinal therapeutics, small-scale on-demand production of personal magistral therapeutics, and exploratory research. The shelf stability and scalability of CFPS systems also have the potential to overcome cost and infrastructure challenges for distributing and using essential medical tests at home in both high- and low-income countries. However, CFPS systems are often more time-consuming and expensive to prepare than traditional in vivo systems, limiting their broader use. Much work has been done to lower CFPS costs by optimizing cell extract preparation, small molecule reagent recipes, and DNA template preparation. In order to further reduce reagent cost and preparation time, this work presents a CFPS system that does not require separately purified DNA template. Instead, a DNA plasmid encoding the recombinant protein is transformed into the cells used to make the extract, and the extract preparation process is modified to allow enough DNA to withstand homogenization-induced shearing. The finished extract contains sufficient levels of intact DNA plasmid for the CFPS system to operate. For a 10 mL scale CFPS system expressing recombinant sfGFP protein for a biosensor, this new system reduces reagent cost by more than half. This system is applied to a proof-of-concept glutamine sensor compatible with smartphone quantification to demonstrate its viability for further cost reduction and use in low-resource settings.
无细胞蛋白质合成(CFPS)是一种多功能生物技术平台,可实现广泛的应用,包括临床诊断、大规模生产药用治疗剂、小规模按需生产个人药剂以及探索性研究。CFPS 系统的货架稳定性和可扩展性也有可能克服成本和基础设施挑战,以便在高收入和低收入国家在家中分发和使用基本医疗测试。然而,CFPS 系统通常比传统的体内系统准备起来更耗时且昂贵,限制了其更广泛的应用。已经做了大量工作来降低 CFPS 的成本,方法是优化细胞提取物的制备、小分子试剂配方和 DNA 模板的制备。为了进一步降低试剂成本和准备时间,这项工作提出了一种不需要单独纯化 DNA 模板的 CFPS 系统。相反,编码重组蛋白的 DNA 质粒被转化为用于制备提取物的细胞,并且修改了提取物制备过程,以使足够的 DNA 能够承受匀浆诱导的剪切。制备好的提取物中含有足够水平的完整 DNA 质粒,足以使 CFPS 系统运行。对于 10 毫升规模的 CFPS 系统,该系统表达用于生物传感器的重组 sfGFP 蛋白,与传统系统相比,该新系统将试剂成本降低了一半以上。该系统应用于与智能手机定量兼容的谷氨酰胺传感器的概念验证,以证明其在进一步降低成本和在资源匮乏环境中使用的可行性。